Intravenous ferric carboxymaltose for the treatment of iron deficiency anemia: Letter to Editor

Intravenous ferric carboxymaltose for the treatment of iron deficiency anemia: Letter to Editor

Bibliographic Details
Main Authors:	Sakiyeva Kanshaiym, Gulmira Zhurabekova, Ibrahim A. Abdelazim, Tatyana Starchenko
Format:	Article
Language:	English
Published:	Elsevier 2020-01-01
Series:	Hematology, Transfusion and Cell Therapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2531137919300537

Similar Items

Intravenous ferric carboxymaltose for the treatment of iron deﬁciency anemia
by: João Ricardo Friedrisch, et al.
Published: (2015-12-01)

Ferric carboxymaltose for treatment of iron deficiency and iron deficiency anemia caused by abnormal uterine bleeding
by: Ahmed Hagras, et al.
Published: (2022-12-01)

Intravenous ferric carboxymaltose for the treatment of iron deficiency anaemia – reply
by: Rodolfo Delfini Cancado, et al.
Published: (2020-01-01)

Successful Procedure in Conservative Management of Interstitial (Cornual) Ectopic Pregnancy
by: Sakiyeva Kanshaiym, et al.
Published: (2019-01-01)

Evaluation of Minimal Optimal Dose of Intravenous Ferric Carboxymaltose for Treatment of Iron Deficiency Anemia and Risk of Transient Hyperferritinemia
by: Alharbi AA, et al.
Published: (2022-11-01)

The role of ferric carboxymaltose in the treatment of iron deficiency anemia in patients with gastrointestinal disease
by: Pramoda Koduru, et al.
Published: (2016-01-01)

Cost-minimization analysis in iron-deficiency anemia comparing intravenous ferric carboxymaltose to standard of care in pregnant women in Algeria
by: Lama Aladham, et al.
Published: (2023-01-01)

Comparison of the use of intravenous iron sucrose with intravenous ferric Carboxymaltose for treatment of iron deficiency anaemia in pregnant patients
by: Khar un-Nisa, et al.
Published: (2022-11-01)

Iron deficiency anemia with menorrhagia: Ferric carboxymaltose a safer alternative to blood transfusion
by: Vineet Mishra, et al.
Published: (2018-01-01)

Cost-minimization analysis favours intravenous ferric carboxymaltose over ferric sucrose for the ambulatory treatment of severe iron deficiency.
by: Xavier Calvet, et al.
Published: (2012-01-01)

Efficacy and cost effectiveness of intravenous ferric carboxymaltose versus iron sucrose in adult patients with iron deficiency anaemia.
by: Ahmad Basha, et al.
Published: (2021-01-01)

Efficacy and cost effectiveness of intravenous ferric carboxymaltose versus iron sucrose in adult patients with iron deficiency anaemia
by: Ahmad Basha, et al.
Published: (2021-01-01)

Efficacy and safety of intravenous ferric carboxymaltose in iron deficiency anemia; Real-life data from Turkey, a single center experience
by: Ali Eser, et al.
Published: (2021-06-01)

Budget Impact of Intravenous Iron Therapy with Ferric Carboxymaltose in Patients with Chronic Heart Failure and Iron Deficiency in Romania
by: Lorenzovici László, et al.
Published: (2019-12-01)

Seven-Year Single-Center Experience of the Efficacy and Safety of Ferric Carboxymaltose in Cancer Patients with Iron-Deficiency Anemia
by: Burak Yasin Aktaş, et al.
Published: (2023-11-01)

Symptomatic severe hypophosphatemia after intravenous ferric carboxymaltose
by: Wendy Fang, et al.
Published: (2019-10-01)

Effectiveness and safety of ferric carboxymaltose compared to iron sucrose in women with iron deficiency anemia: phase IV clinical trials
by: Amreen Naqash, et al.
Published: (2018-01-01)

Acute hypersensitivity reaction following intravenous ferric carboxymaltose injection for iron deficiency anaemia: a case report.
by: Neeraj Kumar, et al.
Published: (2023-03-01)

Patient-Reported Outcomes After Ferric Carboxymaltose Treatment for Iron Deficiency Anemia: A Prospective Observational Study
by: Kwong WJ, et al.
Published: (2023-08-01)

Cost-effectiveness analysis of ferric carboxymaltose iron sucrose for the treatment of iron deficiency anemia in patients with inflammatory bowel disease in Spain
by: Federico Argüelles-Arias, et al.
Published: (2022-05-01)

Ferric Carboxymaltose in the Treatment of Iron-Deficiency Anaemia in Paediatric Patients with Anastomotic Ulcers
by: Chiara Udina, et al.
Published: (2022-03-01)

Intravenous Iron Carboxymaltose as a Potential Therapeutic in Anemia of Inflammation.
by: Niklas Lofruthe, et al.
Published: (2016-01-01)

IV Ferric Carboxymaltose Vs Oral Iron in the Treatment of Post-partum Iron Deficiency Anaemia
by: Sree Chandana Damineni, et al.
Published: (2016-11-01)

Efficacy and Safety of Intravenous Ferric Carboxymaltose Treatment of Iron Deficiency Anaemia in Patients with Corpus Atrophic Gastritis: A Retrospective Study
by: Ludovica Dottori, et al.
Published: (2023-09-01)

Effect of Preoperative Administration of Intravenous Ferric Carboxymaltose in Patients with Iron Deficiency Anemia after Off-Pump Coronary Artery Bypass Grafting: A Randomized Controlled Trial
by: Hyo-Hyun Kim, et al.
Published: (2023-02-01)

Efficacy and Safety of Ferric Carboxymaltose in the Management of Iron Deficiency Anemia: A Multi-Center Real-World Study from India
by: Charmila A, et al.
Published: (2022-06-01)

Efficacy and safety of ferric carboxymaltose versus ferrous sulfate for iron deficiency anemia during pregnancy: subgroup analysis of Korean women
by: Jae-Yoon Shim, et al.
Published: (2018-08-01)

Delayed Hypersensitivity with Ferric Carboxymaltose
by: Surabhi Sridhara, et al.
Published: (2017-11-01)

Maternal Fatigue after Postpartum Anemia Treatment with Intravenous Ferric Carboxymaltose vs. Intravenous Ferric Derisomaltose vs. Oral Ferrous Sulphate: A Randomized Controlled Trial
by: Lea Bombač Tavčar, et al.
Published: (2024-01-01)

Abdelazim and Sakiyeva endocrinopathy associated with polycystic ovary syndrome: Case reports
by: Ibrahim A Abdelazim, et al.
Published: (2019-01-01)

To evaluate the efficacy and safety of intravenous ferrous carboxymaltose compared with Iron sucrose in treating iron deficiency anemia in postpartum period
by: Akriti Gupta, et al.
Published: (2022-12-01)

Ferric carboxymaltose in patients with pulmonary arterial hypertension and iron deficiency: a long‐term study
by: Tilmann Kramer, et al.
Published: (2021-12-01)

A comparative study of ferric carboxymaltose and iron sucrose as a parenteral iron treatment in iron deficiency anemia during pregnancy in a tertiary care hospital
by: Sandip Kumar Ghosh, et al.
Published: (2024-04-01)

P2 Intravenous ferric carboxymaltose for the treatment of refractory restless leg syndrome
by: Jasvinder Kaler, et al.
Published: (2023-10-01)

Impact of intravenous ferric carboxymaltose on heart failure with preserved and reduced ejection fraction
by: Raquel López‐Vilella, et al.
Published: (2022-02-01)

Evaluation of iron stores in hemodialysis patients on maintenance ferric Carboxymaltose dosing
by: Matthias Diebold, et al.
Published: (2019-03-01)

Ferric Carboxymaltose in Patients with Acute Decompensated Heart Failure and Iron Deficiency: A Real-Life Study
by: Federico Capone, et al.
Published: (2023-08-01)

Ferric Carboxymaltose Improves the Quality of Life of Patients with Inflammatory Bowel Disease and Iron Deficiency without Anaemia
by: Jose María Huguet, et al.
Published: (2022-05-01)

Ferric carboxymaltose for the treatment of iron‐deficient heart failure patients: a systematic review and meta‐analysis
by: Muhammad Shahzeb Khan, et al.
Published: (2020-12-01)

Comparative safety of intravenous Ferumoxytol versus Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia: rationale and study design of a randomized double-blind study with a focus on acute hypersensitivity reactions
by: Adkinson NF, et al.
Published: (2017-09-01)